AnaptysBio stock price
어냅티스바이오NASDAQ:ANAB · Nasdaq · Healthcare$48.53-0.21%
2026-10-02 closeLoading chart…
Today's signals · No active technical signal.
Signal details →AnaptysBio last closed at $48.53 (-0.21%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is 8.9×. Its overall grade ranks 198 of 739 stocks in Healthcare.
About this company
AnaptysBio last closed at $48.53 (-0.21%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall A- · 198/739
Valuation grade D
Related stocks
- GSKCustomer
ANB019(rosnilimab) 관련 라이선스·협업 파트너로 연결
- Horizon TherapeuticsCustomer
ANB032/항체 자산 관련 과거 파트너십·라이선스 이력
- Eli LillyCustomer
자가면역·면역질환 항체 플랫폼의 잠재적 대형 제약 파트너
About AnaptysBio
- What technical signals does AnaptysBio (ANAB) have?
- AnaptysBio current technical signals: no active technical signal.
- Is AnaptysBio a cup-and-handle pattern?
- No. AnaptysBio has no valid Cup signal right now.
- What published figures are available for AnaptysBio?
- Market cap: $2.02B. Trailing 12 months PER: 8.9×. Latest quarter PBR: 164.94×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-04 dataset
Turn what you saw on this name into a strategy
Ask Q about AnaptysBio, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy